Legasbi, Vina T.

HRN: 27-45-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
CEFTRIAXONE 1G (VIAL)
07/14/2025
07/20/2025
IV
1g
Q12
Uti
Waiting Final Action 
07/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/14/2025
07/15/2025
IV
500mg
Q8
Amoeba
Checking Initial Appropriateness 
07/14/2025
METRONIDAZOLE 500MG (TAB)
07/15/2025
07/23/2025
ORAL
500mg
Q8
Amoeba
Checking Initial Appropriateness 
07/17/2025
METRONIDAZOLE 500MG (TAB)
07/17/2025
07/24/2025
PO
500mg
TID
Amoebiasis
Checking Initial Appropriateness 
07/17/2025
CEFIXIME 200MG (CAP)
07/17/2025
07/22/2025
PO
200mg
BID
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: